Endobronchial Ultrasound-guided Transbronchial Needle Injection of Liposomal Amphotericin B for the Treatment of Symptomatic Aspergilloma

J Bronchology Interv Pulmonol. 2017 Oct;24(4):330-333. doi: 10.1097/LBR.0000000000000383.

Abstract

Surgical treatment with lung resection has traditionally been the treatment of choice for pulmonary cavities containing aspergillomas that cause hemoptysis. Endobronchial ultrasound (EBUS) is a minimally invasive bronchoscopic technique that is commonly used for transbronchial needle aspiration of hilar and mediastinal lymph nodes as well as centrally located parenchymal lesions. Here, we describe a case of a 71-year-old woman who was found to have a cavitary lesion in the lung containing aspergillomas. Under direct ultrasound visualization with EBUS, liposomal amphotericin B was injected into the aspergillomas. These aspergillomas regressed after treatment. To our knowledge, this is the first reported treatment of aspergilloma with EBUS-guided transbronchial needle injection of liposomal amphotericin B.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Amphotericin B / administration & dosage*
  • Amphotericin B / therapeutic use
  • Antifungal Agents / therapeutic use
  • Endoscopic Ultrasound-Guided Fine Needle Aspiration / methods*
  • Female
  • Humans
  • Lung / pathology
  • Pneumonectomy / standards
  • Pneumonectomy / statistics & numerical data
  • Pulmonary Aspergillosis / diagnostic imaging
  • Pulmonary Aspergillosis / drug therapy*
  • Pulmonary Aspergillosis / pathology
  • Tomography, X-Ray Computed / methods
  • Treatment Outcome
  • Ultrasonography / methods*

Substances

  • Antifungal Agents
  • liposomal amphotericin B
  • Amphotericin B